Australian Personal Products Stock News

Australian United Investment (ASX:AUI) has laid out a steady set of numbers for H1 2026, with total revenue of A$28.0 million and basic EPS of A$0.20 anchoring the latest result. The company has seen revenue move from A$29.4 million in H2 2024 to A$29.0 million in H1 2025 and A$28.0 million in H2 2025, while basic EPS has tracked around A$0.20 across those periods, giving investors a relatively consistent earnings line to work with. With net profit margins sitting at very high levels on a...

Genesis Minerals (ASX:GMD) has reported a busy set of H1 2026 numbers, with total revenue for the latest half at A$581.4 million and basic EPS of A$0.15, compared with a trailing 12 month profile that shows A$1.4 billion of revenue and basic EPS of A$0.36. The company’s revenue has moved from A$222.7 million and EPS of A$0.07 in H2 2024 to A$338.7 million and EPS of A$0.05 in H1 2025, then to A$581.4 million and EPS of A$0.15 in H2 2025. This sets up H1 2026 as another data point in a rapidly...

Bega Cheese (ASX:BGA) has just posted its H1 2026 scorecard, with trailing 12‑month revenue at about A$3.6b and Basic EPS of A$0.03, set against a recent half year that included a one off loss of A$38.2m. Over recent halves, the company has seen revenue move from A$1.79b in H2 2024 to A$1.78b in H1 2025 and A$1.76b in H2 2025, while Basic EPS shifted from A$0.01 in H2 2024 to A$0.10 in H1 2025 and a loss of A$0.13 in H2 2025. This has left investors focused on how quickly margins can rebuild...

Telstra Group (ASX:TLS) has released its H1 2026 scorecard with trailing 12 month revenue of A$23.1 billion and basic EPS of A$0.20, setting a clear benchmark for how the telco is converting its scale into earnings. Over recent periods, the company has seen revenue move from A$11.5 billion in H2 2024 to A$11.6 billion in H1 2025 and A$11.5 billion in H2 2025, while basic EPS shifted from A$0.06 in H2 2024 to A$0.09 in H1 2025 and A$0.10 in H2 2025, giving investors a consistent read on how...

IPH’s H1 2026 earnings in focus IPH (ASX:IPH) has put its latest half on the table with H2 2025 revenue of A$364.6 million and basic EPS of A$0.12, setting the scene for investors weighing up how the business is tracking into H1 2026 on a trailing 12 month view. The company has seen revenue move from A$332.1 million in H2 2024 to A$341.6 million in H1 2025 and then A$364.6 million in H2 2025. Over the same periods, basic EPS went from A$0.16 to A$0.14 and then A$0.12. With trailing 12 month...

On 11 February 2026, Neuren Pharmaceuticals Limited (ASX:NEU) announced a share repurchase program authorizing the buyback and cancellation of up to 6,350,631 shares, or 5% of its 126,639,526 issued shares, with the program running until 2 March 2027. This move reduces the future share count relative to current levels, which can increase each remaining share’s claim on any future earnings and cash flows. We’ll now examine how Neuren’s decision to buy back and cancel up to 5% of its shares...

In February 2026, Computershare reported half-year sales of US$1,559.1 million, slightly lower net income of US$280.4 million, raised full-year 2026 Management EPS guidance to about 144 cps (up around 6%), and announced an ordinary franked dividend of A$0.55 per share for the six months ended December 31, 2025. The combination of higher earnings guidance, attributed to momentum across key business lines, lower interest costs and a completed share buyback, together with an increased dividend...

Lovisa earnings spark fresh look at recent share performance Lovisa Holdings (ASX:LOV) has just released half year results, with sales of A$500.65 million and net income of A$58.39 million. This has drawn fresh attention to a share price that has retreated in recent months. See our latest analysis for Lovisa Holdings. The earnings release comes after a soft patch for the shares, with a 1 day share price return of 12.8% decline and a 30 day share price return of 12.91% decline, while the 5...

nib holdings has recently announced adjustments to its 2026 health insurance premiums across Australian Residents Health Insurance and other segments, reflecting updated regulatory and market conditions. Because premiums are a core revenue lever, these changes may influence nib’s balance between growth, affordability, and claims cost control across its portfolio. We’ll now examine how these 2026 premium adjustments may affect nib holdings’ investment narrative, particularly around revenue...

FireFly Metals Ltd recently reported half-year results to December 31, 2025, reducing its net loss to A$727,000 from A$5.73 million and cutting basic loss per share from A$0.011 to A$0.0011 year-on-year. This sharp improvement in profitability metrics, while still loss-making, points to operational progress that may reshape how investors assess the company’s progress. We’ll now examine how FireFly Metals’ sharply reduced half-year loss might influence its investment narrative and future...

Mesoblast (ASX:MSB) has presented new clinical data for Ryoncil to transplant specialists, reporting consistently high survival outcomes in steroid refractory acute graft versus host disease across multiple patient groups. See our latest analysis for Mesoblast. The latest Ryoncil data arrives after a mixed price run, with Mesoblast’s 90 day share price return of 4.76% contrasting with a 12.64% decline year to date and a three year total shareholder return of 164.49%. This suggests long term...

In recent days, Woolworths Group has come under increased scrutiny ahead of its late-February half-year results, with attention on food retail performance, margin trends, operational upgrades, and ongoing legal challenges in Australia. This combination of operational efficiency initiatives, pricing scrutiny, and regulatory actions is shaping how investors reassess Woolworths’ role within the Australian retail sector. We’ll now examine how regulatory scrutiny over pricing claims and related...

National Australia Bank (ASX:NAB) has kicked off Q1 2026 with a net interest margin of 1.8%, following a 2025 financial year where trailing twelve month revenue was A$20.0 billion and EPS was A$2.22. Over recent quarters, the bank has reported revenue in a range of A$4.90 billion to A$5.21 billion per quarter and quarterly EPS of around A$0.51 to A$0.57, giving investors a clearer view of how earnings are tracking into the new year. With a trailing net profit margin of 33.9%, this update puts...

SHAPE Australia (ASX:SHA) has backed up its latest H1 2026 result with a solid recent track record, with H2 2025 revenue at A$477.9 million and basic EPS of A$0.14, alongside trailing twelve month revenue of A$956.9 million and EPS of A$0.26. The company has seen revenue move from A$423.7 million in H2 2024 to A$478.9 million in H1 2025 and A$477.9 million in H2 2025, while basic EPS has shifted from A$0.10 to A$0.11 and then A$0.14 over the same periods. This gives investors a clear view of...

Clarity Pharmaceuticals recently announced that an abstract from its Co-PSMA Phase II investigator-initiated trial of 64Cu-SAR-bisPSMA has been accepted for oral presentation at the EAU Congress 2026, highlighting data from multiple studies including COBRA, PROPELLER and SECuRE. The trial results indicated that 64Cu-SAR-bisPSMA more than doubled the number of prostate cancer lesions detected per patient versus standard-of-care imaging, with management plans altered in 44% of participants...

Hansen Technologies (ASX:HSN) has backed up its H1 2026 earnings release with a clear lift in the recent run of numbers, with H2 2025 revenue at A$214.2 million, basic EPS of A$0.25 and net income of A$43.3 million. The latest trailing 12 month figures point to net profit margins of 11% compared with 6% a year earlier and earnings growth of 105.7% over the same period. The company has seen revenue move from A$185.2 million in H2 2024 to A$178.3 million in H1 2025 and then A$214.2 million in...

Sonic Healthcare Limited has reported its half-year 2025 results for the period to 31 December 2025, with sales rising to A$5,445.04 million and net income increasing to A$262.49 million, lifting both basic and diluted earnings per share from continuing operations. This marks a shift after a period of weaker profitability, as the company converted higher revenue into improved earnings per share while maintaining consistency between basic and diluted results. We’ll examine how this rebound in...

Australian Foundation Investment Company Limited reported its H1 2026 results on 16 February 2026, outlining portfolio performance, income trends and capital management updates during its earnings call. The call gave investors fresh insight into how the listed investment company is positioning its portfolio in response to evolving market conditions and dividend flows. We’ll now examine how the H1 2026 earnings call, particularly its discussion of portfolio positioning, may shape Australian...

XRF Scientific (ASX:XRF) has just put fresh numbers on the table, with H1 2026 results sitting against a backdrop where revenue in H2 2025 was A$30.7 million and basic EPS was A$0.038, alongside trailing twelve month revenue of A$59.4 million and EPS of A$0.074. Over the past few halves the company has seen revenue move from A$31.5 million in H2 2024 to A$28.7 million in H1 2025 and A$30.7 million in H2 2025, while basic EPS has ranged from A$0.0319 to A$0.038. This sets up a story where...

Chrysos (ASX:C79) has just posted its H1 2026 numbers, with the latest half-year profile shaped by prior period revenue of A$37.0 million and a basic EPS loss of A$0.0486, against a current share price of A$8.03. The company has seen revenue move from A$26.4 million in H2 2024 to A$29.1 million in H1 2025 and then A$37.0 million in H2 2025, while basic EPS shifted from a profit of A$0.0209 in H2 2024 to losses of A$0.0227 and A$0.0486 in the following halves, creating a picture in which top...

Earlier in February 2026, Santana Minerals Limited announced firm commitments for an A$130,000,000 follow-on equity offering at A$0.90 per share, issuing more than 144 million new ordinary shares at a small discount to fund its Bendigo Ophir Gold Project and broader exploration work. A key backdrop to this capital raise is the company’s recently declared extensional Exploration Target at the Rise & Shine deposit, which outlines additional potential mineralisation supported by step-out...

Insignia Financial Ltd. reported half-year results for the period ended 31 December 2025, with sales of A$830 million and net income of A$78.8 million, compared with sales of A$769.9 million and a net loss of A$16.8 million a year earlier. This shift from loss to profit, alongside basic earnings per share from continuing operations improving from a A$0.025 loss to A$0.118 profit, highlights a meaningful turnaround in operating performance. We’ll now examine how Insignia’s return to...

Santos Limited reported full-year 2025 net income of US$818 million, down from US$1,224 million a year earlier, affirmed a US$0.103 per-share final dividend for the half-year to December 31, 2025, and outlined plans to reduce its workforce by about 10% as major projects move into steady-state operations. Alongside confirming unchanged 2026 production and sales guidance, Santos is tightening its cost base through headcount cuts while continuing to return cash to shareholders via...

Brightstar Resources (ASX:BTR) has come into focus after appointing GR Engineering Services as preferred EPC contractor for its planned Goldfields processing plant, a key step toward locking in cost and schedule parameters. See our latest analysis for Brightstar Resources. That EPC appointment comes as momentum in Brightstar’s shares has been mixed, with a 1 day share price return of 5.94% and a 90 day share price return of 17.58% contrasting with a 1 year total shareholder return decline of...